Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 4;137(43):13972-9.
doi: 10.1021/jacs.5b09980. Epub 2015 Oct 23.

Iridium-Catalyzed Enantioselective Allylic Substitution of Enol Silanes from Vinylogous Esters and Amides

Affiliations

Iridium-Catalyzed Enantioselective Allylic Substitution of Enol Silanes from Vinylogous Esters and Amides

Ming Chen et al. J Am Chem Soc. .

Abstract

The enol silanes of vinylogous esters and amides are classic dienes for Diels-Alder reactions. Here, we report their reactivity as nucleophiles in Ir-catalyzed, enantioselective allylic substitution reactions. A variety of allylic carbonates react with these nucleophiles to give allylated products in good yields with high enantioselectivities and excellent branched-to-linear ratios. These reactions occur with KF or alkoxide as the additive, but mechanistic studies suggest that these additives do not activate the enol silanes. Instead, they serve as bases to promote the cyclometalation to generate the active Ir catalyst. The carbonate anion, which was generated from the oxidative addition of the allylic carbonate, likely activates the enol silanes to trigger their activity as nucleophiles for reactions with the allyliridium electrophile. The synthetic utility of this method was illustrated by the synthesis of the anti-muscarinic drug, fesoterodine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed Ir-catalyzed enantioselective allylic substitution with Danishefsky's diene and Rawal's diene.
Figure 2
Figure 2
Representive enantioenriched bisarylalkane containing natural products and pharmaceuticals.
Scheme 1
Scheme 1. Allylic Substitution of 1a with Enol Silane 3 in the Presence of the Ir–Ethylene Complex 7 as the Catalyst
Scheme 2
Scheme 2. Analysis of the Identity and Reactivity of the Resting State of the Catalytic Systema
a(I) Resting state of the reaction with the catalyst generated in situ. (II) Comparison of the reaction at room temperature catalyzed by the cyclometalated ethylene complex 7 and by the catalyst generated in situ.
Scheme 3
Scheme 3. Enantioselective Synthesis of Fesoterodine

References

    1. Danishefsky SJ, Kitahara T. J Am Chem Soc. 1974;96:7807.
    1. Kozmin SA, Rawal VH. J Org Chem. 1997;62:5252.
    1. Kozmin SA, Green MT, Rawal VH. J Org Chem. 1999;64:8045. - PubMed
    2. Huang Y, Rawal VH. J Am Chem Soc. 2002;124:9662. - PubMed
    3. Huang Y, Unni AK, Thadani AN, Rawal VH. Nature. 2003;424:146. - PubMed
    4. Unni AK, Takenaka N, Yamamoto H, Rawal VH. J Am Chem Soc. 2005;127:1336. - PubMed
    5. Panarese JD, Waters SP. Org Lett. 2009;11:5086. - PMC - PubMed
    6. Zhang Y, Danishefsky SJ. J Am Chem Soc. 2010;132:9567. - PMC - PubMed
    1. Acocella MR, De Rosa M, Massa A, Palombi L, Villano R, Scettri A. Tetrahedron. 2005;61:4091.
    2. Attanasi OA, Favi G, Filippone P, Giorgi G, Mantellini F, Moscatelli G, Spinelli D. Org Lett. 2008;10:1983. - PubMed
    3. De Rosa M, Soriente A. Tetrahedron. 2011;67:5949.
    1. Liu Y, Bakshi K, Zavalij P, Doyle MP. Org Lett. 2010;12:4304. - PMC - PubMed
    2. Ohtani T, Tsukamoto S, Kanda H, Misawa K, Urakawa Y, Fujimaki T, Imoto M, Takahashi Y, Takahashi D, Toshima K. Org Lett. 2010;12:5068. - PubMed
    3. Guéret SM, Furkert DP, Brimble MA. Org Lett. 2010;12:5226. - PubMed
    4. Hiraoka S, Harada S, Nishida A. J Org Chem. 2010;75:3871. - PubMed
    5. Fujiwara K, Tanaka K, Katagiri Y, Kawai H, Suzuki T. Tetrahedron Lett. 2010;51:4543.
    6. Liu Y, Doyle MP. Org Biomol Chem. 2012;10:6388. - PubMed
    7. Kondratov IS, Dolovanyuk VG, Tolmachova NA, Gerus II, Bergander K, Fröhlich R, Haufe G. Org Biomol Chem. 2012;10:8778. - PubMed
    8. Li B, Widlicka D, Boucher S, Hayward C, Lucas J, Murray JC, O'Neil BT, Pfisterer D, Samp L, VanAlsten J, Xiang YQ, Young J. Org Process Res Dev. 2012;16:2031.
    9. Edwankar RV, Edwankar CR, Namjoshi OA, Deschamps JR, Cook JM. J Nat Prod. 2012;75:181. - PMC - PubMed
    10. Arnold DM, LaPorte MG, Anderson SM, Wipf P. Tetrahedron. 2013;69:7719. - PMC - PubMed
    11. Desrosiers JN, Kelly CB, Fandrick DR, Nummy L, Campbell SJ, Wei X, Sarvestani M, Lee H, Sienkiewicz A, Sanyal S, Zeng X, Grinberg N, Ma S, Song JJ, Senanayake CH. Org Lett. 2014;16:1724. - PubMed
    12. Wu B, He S, Wu Xd, Pan Yj. Planta Med. 2006;72:1334. - PubMed

Publication types

MeSH terms